{{PBB|geneid=1557}}
细胞色素P450 2C19酶（简称，'''CYP2C19'''），也称为''S-美芬妥英羟化酶''。这种蛋白质是[[细胞色素P450|细胞色素P450]]多功能氧化酶系统的成员，参与[[异型生物质|异型生物质]]（如许多''[[质子泵|质子泵]]''<ref>{{lang-en|proton pump}}</ref>抑制剂和''[[镇痛剂|镇痛剂]]''<ref>{{lang-en|antiepileptic}}</ref>）的代谢。对于人类而言，CYP2C19蛋白由''CYP2C19''基因编码。<ref name="pmid2009263">{{cite journal | author = Romkes M, Faletto MB, Blaisdell JA, Raucy JL, Goldstein JA | title = Cloning and expression of complementary DNAs for multiple members of the human cytochrome P450IIC subfamily | journal = Biochemistry | volume = 30 | issue = 13 | pages = 3247–55 |date=April 1991 | pmid = 2009263 | doi = 10.1021/bi00227a012| url =  }}</ref><ref name="pmid8530044">{{cite journal | author = Gray IC, Nobile C, Muresu R, Ford S, Spurr NK | title = A 2.4-megabase physical   map spanning the CYP2C gene cluster on chromosome 10q24 | journal = Genomics | volume = 28 | issue = 2 | pages = 328–32 |date=July 1995 | pmid = 8530044 | doi = 10.1006/geno.1995.1149 | url =  }}</ref>CYP2C19 作为一种[[肝脏|肝脏]]酶影响着当前药物的5-10%的临床使用，<ref>{{cite web|title=Cytochrome P450 2C19 Genotyping|url=http://genelex.com/pharmacogenetic-tests/cyp2c19/|website=Genele X|accessdate=October 2014|archive-date=2014-11-15|archive-url=https://web.archive.org/web/20141115181902/http://genelex.com/pharmacogenetic-tests/cyp2c19/|dead-url=no}}</ref> 例如抗凝剂[[克拉匹多|克拉匹多]]（又''[[氯吡格雷|氯吡格雷]]''<ref>{{lang-en|clopidogrel}}</ref>，商品名''波立维''<ref>{{lang-en|Plavix}}</ref>),抗溃疡药物''[[奥美拉唑|奥美拉唑]]''<ref name="#1">{{lang-en|omeprazole}}</ref>，抗癫痫药物''[[美芬妥因|美芬妥因]]''<ref name="#1"/>，抗疟疾药物''[[氯胍|氯胍]]''<ref>{{lang-en|proguanil}}</ref>和抗焦虑药''[[地西泮|安定]]''<ref>{{lang-en|diazepam}}</ref>。<ref>{{cite web|title=Cytochrome P450 2C19 (CYP2C19) Genotype|url=http://www.mayomedicallaboratories.com/articles/features/cyp2c19/index.html|website=Mayo Medical Laboratories|accessdate=October 2014|deadurl=yes|archiveurl=https://web.archive.org/web/20141012090749/http://www.mayomedicallaboratories.com/articles/features/cyp2c19/index.html|archivedate=2014-10-12}}</ref>

==[[遗传多态性|遗传多态性]]==
''CYP2C19''基因具有遗传多态性，其遗传多态性及缺陷是S-美芬妥英羟化代谢遗传多态性及种族差异的分子基础。不同种族之间，如白种人与东方人种之间，其活性也存在着差异。''CYP2C19''基因对CYP2C19酶活性有重要作用。''CYP2C19''基因突变不仅影响CYP2C19酶活性，而且也影响CYP2C19的抑制和诱导。

==注释及参考文献==
<references />

{{Cytochrome P450}}
[[Category:细胞色素P450|2]]